Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study

Authors: Marabelle, Aurelien ^*, Cassier, Philippe A, Fakih, Marwan, Kao, Steven, Nielsen, Dorte, Italiano, Antoine, Guren, Tormod Kyrre, van Dongen, Marloes G J, Spencer, Kristen, Bariani, Giovanni Mendonca, Ascierto, Paolo A, Santoro, Armando, Shah, Manisha, Asselah, Jamil, Iqbal, Syma, Takahashi, Shunji, Piha-Paul, Sarina A, Ott, Patrick A, Chatterjee, Arkendu, Jin, Fan, Norwood, Kevin, Delord, Jean-Pierre

Source: In The Lancet Gastroenterology & Hepatology May 2022 7(5):446-454

Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial

Authors: Romera, Alvaro, Peredpaya, Sergiy, Shparyk, Yaroslav, Bondarenko, Igor, Mendonça Bariani, Giovanni, Abdalla, Kathia Cristina, Roca, Enrique, Franke, Fábio, Melo Cruz, Felipe, Ramesh, Anita, Ostwal, Vikas, Shah, Pradeep, Rahuman, Sajeed Abdul, Paravisini, Alexandra, Huerga, Camino, Del Campo García, Ana, Millán, Susana

Source: In The Lancet Gastroenterology & Hepatology December 2018 3(12):845-855

Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer

Authors: Miranda, Vanessa C., Braghiroli, Maria Ignez, Faria, Luiza Dib, Bariani, Giovanni, Alex, Alexandra, Bezerra Neto, João Evangelista, Capareli, Fernanda C., Sabbaga, Jorge, Lobo dos Santos, Juliana Ferreira, Hoff, Paulo M., Riechelmann, Rachel P.

Source: In Clinical Colorectal Cancer December 2016 15(4):321-328

Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study.

Authors: O'Malley, David M, Bariani, Giovanni Mendonca, Cassier, Philippe A, Marabelle, Aurelien, Hansen, Aaron R, De Jesus Acosta, Ana, Miller, Wilson H Jr, Safra, Tamar, Italiano, Antoine, Mileshkin, Linda, Xu, Lei, Jin, Fan, Norwood, Kevin, Maio, Michele

Source: Journal of Clinical Oncology; 3/1/2022, Vol. 40 Issue 7, p752-761, 10p

Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care.

Authors: Blayney, Douglas W.¹ (AUTHOR) DBlayney@stanford.edu, Bariani, Giovanni² (AUTHOR), Das, Devika³ (AUTHOR), Dawood, Shaheenah⁴ (AUTHOR), Gnant, Michael⁵ (AUTHOR), De Guzman, Roselle⁶ (AUTHOR), Martin, S. Eric⁷ (AUTHOR), O'Mahony, Deirdre⁸ (AUTHOR), Roach, Alex⁹ (AUTHOR), Ruff, Paul¹⁰ (AUTHOR), Sampaio, Carlos¹¹ (AUTHOR), Sanchez, Jose Angel¹² (AUTHOR), Vanderpuye, Verna¹³ (AUTHOR), Kamal, Arif¹⁴ (AUTHOR), Hendricks, Carolyn¹⁵ (AUTHOR)

Source: JCO Global Oncology. 10/29/2021, Vol. 7, p1513-1521. 9p.

Subject Terms: *COVID-19, *COVID-19 pandemic, *CANCER treatment, *MEDICAL personnel, *COVID-19 treatment

This result is not displayed to guests.
Login for full access.

Regorafenib in Patients with Antiangiogenic‐Naïve and Chemotherapy‐Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial.

Authors: Riechelmann, Rachel P., Leite, Luiz S., Bariani, Giovanni M., Glasberg, Joao, Rivelli, Thomas G., da Fonseca, Leonardo Gomes, Nebuloni, Daniela R., Braghiroli, Maria I., Queiroz, Marcelo A., Isejima, Alice M., Kappeler, Christian, Kikuchi, Luciana, Hoff, Paulo M.

Source: Oncologist; Sep2019, Vol. 24 Issue 9, p1180-1187, 8p, 2 Charts, 2 Graphs

Subject Terms: HYPERTENSION risk factors, NEOVASCULARIZATION inhibitors, CANCER chemotherapy, CLINICAL trials, COLON tumors, CONFIDENCE intervals, NONPROFIT organizations, RECTUM tumors, TUMOR classification, PROTEIN-tyrosine kinase inhibitors, TREATMENT effectiveness, DISEASE progression, HYPOPHOSPHATEMIA, HAND-foot syndrome, TUMOR grading, DISEASE risk factors, THERAPEUTICS

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Evaluation of ¹⁸F-FDG PET-CT as a prognostic marker in advanced biliary tract cancer.

Authors: Braghiroli, Maria I., Mota, José M., Duarte, Paulo S., Morita, Tiago O., Bariani, Giovanni M., Nebuloni, Daniela, Buchpiguel, Carlos A., Hoff, Paulo M., Riechelmann, Rachel P.

Source: Nuclear Medicine Communications; Mar2018, Vol. 39 Issue 3, p252-259, 8p, 4 Black and White Photographs, 2 Charts, 3 Graphs

Evaluation of 18F-FDG PET-CT as a prognostic marker in advanced biliary tract cancer

Authors: Braghiroli, Maria I., Mota, José M., Duarte, Paulo S., Morita, Tiago O., Bariani, Giovanni M., Nebuloni, Daniela, Buchpiguel, Carlos A., Hoff, Paulo M., Riechelmann, Rachel P.

Source: Nuclear Medicine Communications; March 2018, Vol. 39 Issue: 3 p252-259, 8p

This result is not displayed to guests.
Login for full access.

Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.

Authors: Oliveira, Suilane, Moniz, Camila, Riechelmann, Rachel, Alex, Alexandra, Braghirolli, Maria, Bariani, Giovanni, Nahas, Caio, Hoff, Paulo

Source: Journal of Gastrointestinal Cancer; Mar2016, Vol. 47 Issue 1, p75-81, 7p

Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas.

Authors: Munhoz, Rodrigo Ramella, De Mendonça Rego, Juliana Florinda, De Celis Ferrari, Anezka Rubim, Braghiroli, Maria Ignez, Bariani, Giovanni Mendonça, Hoff, Paulo Marcelo, Costa, Frederico Perego, Flesch Pfiffer, Túlio Eduardo, Riechelmann, Rachel

Source: Rare Tumors; 2013, Vol. 5 Issue 3, p135-139, 5p

Subject Terms: IRINOTECAN, NEUROENDOCRINE tumors, CANCER chemotherapy, CISPLATIN, LUNG cancer

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Poor Evidence to Standardize Adjuvant Treatment for Patients With Biliary Tract Cancer.

Authors: Bariani, Giovanni M., Braghiroli, Maria Ignez, Riechelmann, Rachel P., Horgan, Anne M., Knox, Jennifer J.

Source: Journal of Clinical Oncology; 11/20/2012, Vol. 30 Issue 33, p4173-4174, 2p